Donors agree financial arrangement to stimulate vaccine developmentBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39545.371956.DB (Published 10 April 2008) Cite this as: BMJ 2008;336:797
- Andrew Jack
- 1Financial Times
An innovative financial mechanism designed to boost the development and distribution of vaccines in the developing world is set to launch next year, after publication of an expert report this month on how it will work.
Under the advance market commitment scheme, donor countries promise to buy specified vaccines from the companies that develop them for use in poor countries, which guarantees firms a market for their products.
The first advance market commitment set to be formally approved in June by donors that are contributing $1.5bn (£750m; €960m) is designed to stimulate the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial